methylprednisolone has been researched along with Paronychia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burbujo, J; Calderón-Komaromy, A; Córdoba, S; de Pablo, NP; Freites-Martínez, A; Martinez-Sánchez, D | 1 |
| Baran, R; Hay, RJ | 1 |
| Montgomery, BD | 1 |
| Gordon, RJ; Osterwalder, B; Planting, AS; Pronk, LC; Reigner, B; Sparreboom, A; Twelves, C; Vasey, P; Verweij, J | 1 |
| Colombo, MD; Ghetti, E; Piraccini, BM; Tosti, A | 1 |
2 trial(s) available for methylprednisolone and Paronychia
| Article | Year |
|---|---|
A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Biotransformation; Capecitabine; Carboxylic Ester Hydrolases; Deamination; Deoxycytidine; Dexamethasone; Docetaxel; Drug Administration Schedule; Female; Fever; Fluorouracil; Gastrointestinal Diseases; Humans; Infusions, Intravenous; Liver; Male; Maximum Tolerated Dose; Methylprednisolone; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Paronychia; Prodrugs; Remission Induction; Taxoids; Treatment Outcome | 2000 |
Topical steroids versus systemic antifungals in the treatment of chronic paronychia: an open, randomized double-blind and double dummy study.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Antifungal Agents; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Itraconazole; Male; Methylprednisolone; Middle Aged; Naphthalenes; Paronychia; Probability; Terbinafine; Treatment Outcome | 2002 |
3 other study(ies) available for methylprednisolone and Paronychia
| Article | Year |
|---|---|
[Exudative onycholysis and acute bacterial paronychia related to BIBF-1120 and paclitaxel: response to topical therapy].
Topics: Angiogenesis Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Susceptibility; Female; Fusidic Acid; Hand; Humans; Indoles; Methylprednisolone; Middle Aged; Onycholysis; Paclitaxel; Paronychia; Staphylococcal Skin Infections | 2014 |
Onychomycosis: a proposed revision of the clinical classification.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Dermatomycoses; Female; Food Handling; Foot Dermatoses; HIV Infections; Humans; Male; Methylprednisolone; Nail Diseases; Occupational Diseases; Onychomycosis; Opportunistic Infections; Paronychia; Skin Diseases | 2011 |
Chronic paronychia--putting a finger on the evidence.
Topics: Administration, Topical; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antifungal Agents; Candida; Chronic Disease; Dermatitis; Humans; Male; Methylprednisolone; Nail Diseases; Nails; Paronychia | 2006 |